You are currently browsing the category archive for the ‘FTSE Aim’ category.

Serica Energy (SQZ, 58p) announced yesterday September 29th that six directors had bought shares in the company on September 26th at prices between 49p and 53p. They also announced that they had the same day (September 26th) received a written share offer from Salamander valuing the shares at 70p. Link to both announcements here.

I’ve a few questions of Serica management:

1. Did you buy shares on the 26th September before or after you had received the wriiten offer from Salamander (valuing the share offer for Serica at 70p using the September 26th closing prices of Salamander and Serica)?

2. Had you received a verbal offer from Salamander prior to the written offer? And was that before or after you bought shares for yourselves?

3. Were you in discussions which may or may not have led to an offer for the company at the time you bought shares on August 15th (see my post of  August 16th ‘Serica – Three directors invest GBP 440k’) ?

My view of August 16th was

‘I consider Fridays purchases to be more significant as three directors are buying, investing significant amounts, and increasing their positions by an average of 20%. Signal strength: STRONG’.

With now 6 directors of a board of 8 buying shares, and an offer on the table, my view remains positive based on the value of directors share dealings in Serica Energy.

Signal Strength remains STRONG.

Disclosure: I have a position in Serica Energy.

‘Founded over twenty years ago, System C has built up expertise in nearly every area of healthcare IT and medical software interfacing.  System C works right across the healthcare sector, and with all types of clinical information systems, including patient-based IT systems.’  (Source- System C Healthcare website)

I was drawn to this stock by a flurry of director activity, where three directors invested [a small amount of money] around GBP 16k-20k each (September 10th, Ian Denley CEO, Markus Bolton Strategy and Sales, and Andrew Coll CFO- source London Stock Exchange).

Whilst not significant in $$ size or % increase in holdings, having the CEO, CFO and Head of Sales and Strategy all buying shares 50% more expensive than last week certainly got me thinking.

At the end of May (then 28p) System C Healthcare (SYS,now 42p) announced they would beat market expectations. They clearly have, given the share price move.

These are the first directors share purchases since System C was listed on AIM at 54p in June 2005.

Have a look at the results, especially the high level of cash generation.

I’d have this as a ‘STRONG signal’ if the directors purchases were more substantial.

Until then System C’s director dealing activity justifies a  ‘MEDIUM strength signal’

Add to Technorati Favorites

Prefer to get emails? Click here

RSS Find us on

  • An error has occurred; the feed is probably down. Try again later.


June 2022